Perrigo gets FDA approval to manufacture milk-based infant formulas
ALLEGAN, Mich. The Food and Drug Administration has given Perrigo the go-ahead to manufacture milk-based infant formulas through its partner, Saint-Claire, Quebec-based Kerry Proteins and Nutritionals, Perrigo said Wednesday.
The company received FDA clearance to market milk-based, ready-to-use and concentrate infant formulas with ARA and DHA in 8-oz. and 13-oz. bottles, and milk-based organic infant formula in 8-oz. bottles.
“We are excited to receive FDA clearance on these new liquid concentrate and ready-to-use products, and to expand our portfolio of nonpowder infant formula products,” Perrigo chairman and CEO Joseph Papa stated. “This is the first launch of new products since acquiring our infant nutrition business, and we look forward to further new product introductions.”
Greenwood Group, NCL & Associates announce strategic alliance
BUFFALO, N.Y. Greenwood Group and NCL & Associates on Tuesday announced a strategic alliance designed to offer a wide variety of services to companies that are at various stages of their development and to provide a platform for success.
Effective Sept. 1, NCL will focus its consulting work in four core areas — diabetes products, services and information; pre-market and pre-commercialization of healthcare products and related services; private equity/venture capital assistance and research; and consulting for retailers, wholesalers and other trade channels.
“NCL & Associates has consulted in these areas prior to me taking full-time positions with Bayer HealthCare as director of trade sales and marketing for [its] diabetes care division and then at Greenwood as VP strategy and consulting,” stated Neil Luckianow, head of NCL. “Re-opening NCL & Associates provides a venue to utilize my strength and supply clients with a focus on outcomes-based research with an emphasis for getting the businesses ready for their next phase and execution. NCL will furnish an integral precommercialization consulting role and deliver a variety of skills and experience to each project.”
“[Luckianow] has been a tremendous resource for us for the past 15 months” commented Patrick O’Leary, Greenwood Group president. “The greatest strength of this partnership is that we will continue everything we began just over a year ago. With NCL, we’ll both get a more independent view of the business environment, which we feel will help our constituents. Both of our companies, as a result, will perform even better and in the end net the kind of outcome that keeps us on our main task — building businesses.”
“From early-stage research and strategic planning through execution of plans and programs, this alliance will give us the opportunity to custom fit a number of services to each client’s business needs,” Luckianow added.
W. F. Young updates brand image
EAST LONGMEADOW, Mass. W. F. Young on Monday introduced new packaging graphics that not only will serve to contemporize the brand but also marks the celebration of the company’s heritage of providing pain-relief products for horses.
Most consumers are not aware that the company’s first introduction into the pain-relief market actually was a product formulated for horses, the company noted. Absorbine Veterinary Liniment was introduced in 1892 by Wilbur F. and Mary Ida Young as a liniment to relieve the muscle pain of horses.
This inspired the introduction of Absorbine Jr. in 1903 to help relieve the muscle aches and pains of people.
The new carton and label graphics reflect W. F. Young’s horse care heritage with a graphic depicting a powerful horse next to a fit, healthy runner. The product with the new packaging started shipping in June and is appearing on store shelves now.